Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7709540

[Ways to decrease postoperative hypothyroidism in patients with diffuse toxic goiter].

Iu B Kirillov·V G Aristarkhov·I V Panteleev·A A Potapov·A P Korviakov·A V Poliakov
View original source ↗Export metadata ↓

Abstract

The authors note that postoperative hypothyrosis is observed much more often than recurrences of thyrotoxicosis in patients with diffuse toxic goiter. The incidence of hypothyrosis is associated with the amount of the remnants of tissue, its functional abilities, regeneration, state of the hormonal and immune systems of the organism. The authors describe their method of determining the mass of the thyroid residue. The incidence of hypothyrosis was reduced from 43 up to 18%.

Explore related subjects

Follow-Up StudiesGraves DiseaseHumansHypothyroidismOrgan SizePostoperative ComplicationsThyroid GlandThyroidectomyEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Iu B Kirillov, V G Aristarkhov, I V Panteleev, A A Potapov, A P Korviakov, A V Poliakov. [Ways to decrease postoperative hypothyroidism in patients with diffuse toxic goiter].. https://pubmed.ncbi.nlm.nih.gov/7709540/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Posttreatment follow-up of radiation oncology patients in a managed care environment.

PURPOSE: Health care delivery in the United States is in the midst of a structural revolution called managed care. Demands for cost control within the managed care environment force radiation oncologists to defend the need and obligation to follow their patients. METHODS AND MATERIALS: We have analyzed this follow-up requirement from six potential justifications: patient care, medical-legal, quality assurance, outcome measurement, cost, and improvement of care. RESULTS: Practical recommendations for discussing the need for follow-up with the medical directors and primary care physicians of managed care entities are given. Follow-up without valid documentation of benefit is hard to justify in this era of managed care. CONCLUSIONS: Collaborative follow-up between the referring physician, the treating radiation oncologist, and the other oncologic specialists will allow for outcome measurement and improvement in practice without driving up cost or exposing the patient to undue risk.

Follow-Up Studies↗